Juvenile Diabetes Research Foundation to Fund Collaboration between University of Michigan and PCAsso Diagnostics LLC.

NORTH BRUNSWICK, N.J.--(EON: Enhanced Online News)--PCAsso Diagnostics LLC today announced that Juvenile Diabetes Research Foundation (JDRF) will fund a research collaboration between University of Michigan and PCAsso Diagnostics LLC. The purpose of this collaboration is to assess the feasibility of using PolyChromatic Angiography (PCA) in the evaluation of disease severity in animal models with ocular pathology resembling diabetic retinopathy.

“This is a perfect example where philanthropy, academia and industry join forces to advance a disruptive technology to benefit the public.”

The collaboration will be led by David A. Antonetti, PhD, Jules and Doris Stein Professor at the Departments of Ophthalmology and Visual Sciences and Molecular and Integrative Physiology at the Kellogg Eye Center at the University of Michigan. Dr. Antonetti is a leading scientist in the field of vascular pathology in diabetic retinopathy. “We are excited to explore the use of this new technology in the assessment of vascular pathology in our animal models,” said Dr. Antonetti.

“This is a perfect example where philanthropy, academia and industry join forces to advance a disruptive technology to benefit the public.” said Samir R. Tari, MD, founder and CEO of PCAsso Diagnostics LLC.

The collaboration is scheduled to start in September, 2011 and will last for a year.

About PolyChromatic Angiography

PolyChromatic Angiography (PCA) is a novel imaging technology that is expected to provide semi-quantitative analysis of vascular leakage in the retina. The granular information provided by PCA may help ophthalmologists grade disease severity more accurately and tailor treatment accordingly to prevent both under-treatment and over-treatment of retinal vascular diseases.

About PCAsso Diagnostics LLC

PCAsso Diagnostics, LLC is a privately-owned diagnostics company located in North Brunswick, New Jersey committed to the identification and development of novel medical diagnostic technologies. For more information about PCAsso, please visit www.pcasso.org.

About The University of Michigan Kellogg Eye Center

The University of Michigan Kellogg Eye Center is a nationally known center for eye care, education and research. With over 125,000 patient visits each year, the Eye Center provides routine examinations and advanced eye care to its many patients. Kellogg is home to the Department of Ophthalmology and Visual Sciences for the U-M Health System. Through basic science and clinical research, Kellogg scientists are advancing knowledge of the causes and mechanisms underlying eye disease, and they are dedicated to developing new therapies and treatments for blinding eye disease. For more information about Kellogg Eye Center, please visit www.kellogg.umich.edu.

About JDRF

JDRF is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. For more information, please visit www.jdrf.org.